WallStreetZenWallStreetZen

NASDAQ: URGN
Urogen Pharma Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Urogen Pharma earnings were -$138.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest URGN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$43.8M, up 16.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, URGN reported annual earnings of -$126.9M, with 24.1% growth.

URGN earnings history

Current Revenue
$91.9M
Current Earnings
-$138.4M
Current Profit Margin
-150.7%

URGN Return on Equity

Current Company
-97,486.6%
Current Industry
-60.2%
Current Market
31.5%
URGN's Return on Equity (-97,486.6%)... subscribe to Premium to read more.
High Return on Equity Performance

URGN undefined

Current Company
-49.6%
Current Industry
-2.5%
URGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when URGN announces earnings.

URGN undefined

Current Company
-58.9%
Current Industry
5.8%
URGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

URGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
URGN-$119.79M-$138.43MN/A-$2.98
TYRA-$95.90M-$96.44MN/A-$1.63
RLAY-$328.11M-$333.39MN/A-$2.20
KURA-$177.19M-$181.89MN/A-$2.10
KROS$17.92M$4.21MN/A-$0.12
View Top Biotech Stocks

Urogen Pharma Earnings Reports & History FAQ

What were Urogen Pharma's earnings last quarter?

On URGN's earnings call on Invalid Date, Urogen Pharma (NASDAQ: URGN) reported Q1 2025 earnings per share (EPS) of -$0.92, up 5.75% year over year. Total URGN earnings for the quarter were -$43.84 million. In the same quarter last year, Urogen Pharma's earnings per share (EPS) was -$0.87.

If you're new to stock investing, here's how to buy Urogen Pharma stock.

Is Urogen Pharma profitable or losing money?

As of the last Urogen Pharma earnings report, Urogen Pharma is currently losing money. Urogen Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$138.43 million, a 32.7% increase year over year.

What was URGN's earnings growth in the past year?

As of Urogen Pharma's earnings date in Invalid Date, Urogen Pharma's earnings has grown year over year. URGN earnings in the past year totalled -$138.43 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.